Planet 13 Holdings (PLNH) Gains from Investment Securities (2021 - 2023)
Planet 13 Holdings (PLNH) posted quarterly Gains from Investment Securities of -$18127.0 for Q1 2023, up 99.57% year-over-year from -$9082.8 in Q1 2022, and up 90.19% quarter-over-quarter from -$184850.0 in Q4 2022.
Planet 13 Holdings (PLNH) Gains from Investment Securities (2021 - 2023) Analysis & Trends
Planet 13 Holdings (PLNH) has reported Gains from Investment Securities for 3 consecutive years, with -$18127.0 the latest figure, recorded in Q1 2023.
- In Q1 2023, Gains from Investment Securities rose 99.57% year-over-year to -$18127.0; the TTM figure through Dec 2023 stood at -$18127.0 (up 99.75% YoY), while the FY2023 annual figure was -$18127.0, up 99.75% from the prior year.
- Gains from Investment Securities grew to -$18127.0 in Q1 2023 per PLNH's latest filing, from -$184850.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $9.3 million in Q2 2021 and bottomed at -$6.5 million in Q3 2021.
- Historically, Gains from Investment Securities has averaged -$800383.6 across 3 years, with a median of -$197721.0 in 2022.
- Annual changes were most pronounced in 2022 — Gains from Investment Securities slumped 29028.91% — and 2023, when it jumped 99.57%.
- Planet 13 Holdings' Gains from Investment Securities stood at -$2.7 million in 2021, then surged by 93.24% to -$184850.0 in 2022, then jumped by 90.19% to -$18127.0 in 2023.
- Business Quant data shows PLNH's Gains from Investment Securities at -$18127.0 in Q1 2023, -$184850.0 in Q4 2022, and -$197721.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Planet 13 Holdings | 52.91 Mn | 36.42 Mn | 12.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -18,127.00 |
| Mar 31, 2023 | -18,127.00 |
| Dec 31, 2022 | -184,850.00 |
| Dec 31, 2022 | -184,850.00 |
| Sep 30, 2022 | -197,721.00 |
| Sep 30, 2022 | -197,721.00 |
| Jun 30, 2022 | -2.53 Mn |
| Jun 30, 2022 | -2.53 Mn |
| Mar 31, 2022 | -4.26 Mn |
| Mar 31, 2022 | -4.26 Mn |
| Dec 31, 2021 | -2.74 Mn |
| Dec 31, 2021 | -2.74 Mn |
| Sep 30, 2021 | -6.52 Mn |
| Sep 30, 2021 | -6.52 Mn |
| Jun 30, 2021 | 9.27 Mn |
| Jun 30, 2021 | 9.27 Mn |
| Mar 31, 2021 | -14,641.00 |
| Mar 31, 2021 | -14,641.00 |